ARENA PHARMACEUTICALS INC's ticker is ARNA and the CUSIP is 040047607. A total of 163 filers reported holding ARENA PHARMACEUTICALS INC in Q3 2018. The put-call ratio across all filers is 0.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $68,102,000 | +310.7% | 732,746 | +163.1% | 0.03% | +240.0% |
| Q3 2021 | $16,582,000 | +53.1% | 278,458 | +75.3% | 0.01% | +42.9% |
| Q2 2021 | $10,833,000 | +28.8% | 158,847 | +31.0% | 0.01% | +16.7% |
| Q1 2021 | $8,411,000 | -13.7% | 121,214 | -4.5% | 0.01% | -14.3% |
| Q4 2020 | $9,747,000 | -20.9% | 126,864 | -23.0% | 0.01% | -53.3% |
| Q3 2020 | $12,327,000 | -25.8% | 164,818 | -37.6% | 0.02% | -34.8% |
| Q2 2020 | $16,614,000 | +228.3% | 263,920 | +119.1% | 0.02% | +109.1% |
| Q1 2020 | $5,060,000 | -49.4% | 120,483 | -45.3% | 0.01% | -15.4% |
| Q4 2019 | $9,997,000 | +62.8% | 220,106 | +64.1% | 0.01% | +30.0% |
| Q3 2019 | $6,140,000 | -17.9% | 134,160 | +5.1% | 0.01% | -9.1% |
| Q2 2019 | $7,481,000 | +537.2% | 127,595 | +323.2% | 0.01% | +450.0% |
| Q4 2018 | $1,174,000 | -85.5% | 30,148 | -82.9% | 0.00% | -80.0% |
| Q3 2018 | $8,099,000 | +193.9% | 175,991 | +178.4% | 0.01% | +150.0% |
| Q2 2018 | $2,756,000 | -88.5% | 63,213 | -89.6% | 0.00% | -87.5% |
| Q1 2018 | $23,942,000 | -11.8% | 606,130 | -24.1% | 0.03% | -13.5% |
| Q4 2017 | $27,135,000 | +11.4% | 798,789 | -16.4% | 0.04% | 0.0% |
| Q3 2017 | $24,359,000 | +95.9% | 955,250 | +29.6% | 0.04% | +60.9% |
| Q2 2017 | $12,437,000 | – | 737,225 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prosight Management, LP | 252,500 | $11,320,000 | 4.95% |
| Rubric Capital Management LP | 857,103 | $38,424,000 | 3.59% |
| PFM Health Sciences, LP | 3,255,230 | $145,932,000 | 3.22% |
| Partner Investment Management, L.P. | 40,605 | $1,820,000 | 2.10% |
| DAFNA Capital Management LLC | 93,942 | $4,211,000 | 1.82% |
| Atika Capital Management LLC | 195,000 | $8,742,000 | 1.78% |
| Perceptive Advisors | 1,400,171 | $62,770,000 | 1.77% |
| EMORY UNIVERSITY | 47,779 | $2,142,000 | 1.51% |
| Rhenman & Partners Asset Management AB | 234,558 | $10,515,000 | 1.23% |
| Eversept Partners, LP | 75,721 | $3,394,572 | 0.99% |